Although CTLA-4 deficiency, first linked to autoimmune lymphoproliferative syndrome (ALPS)-like dysregulation in 2014 (10, 11), is predominantly diagnosed in adults, the majority of reported cases manifest initial symptoms before age 18. This evidence concerns the gene CTLA4 and autoimmune lymphoproliferative syndrome.